Advertisement
Home Blog Page 3294
The first case of Alzheimer's disease (AD) diagnosed in a person with HIV suggests progressive dementia in older HIV+ individuals may be due to HIV-associated neurocognitive disorder

Novel Case of Alzheimer’s Reported in HIV+ Patient

0
Amyloid PET imaging may help distinguish AD from HIV-associated neurocognitive disorder
Implantation of sliding growth guidance instrumentation LSZ-4D

Metal Up in Blood With Titanium Growth Guidance Sliding Device

0
Increased content of metal ion in blood and tissue around implanted device in children with scoliosis
Many breast cancer patients receive chemotherapy they don't need

AACR: Many Breast Cancer Patients May Not Need Chemo

0
Genetic test can help doctors determine who can safely avoid treatment after surgery
For perimenopausal and postmenopausal women

Review: Paroxetine Reduces Vasomotor Symptoms

0
Moderate quality evidence shows reduction in frequency of hot flashes with paroxetine
For renal transplant recipients

Oral Nicotinamide Safe for Renal Transplant Recipients

0
Treatment linked to nonsignificant reductions in new non-melanoma skin cancers
For patients with post-myocardial infarction heart failure

Mineralocorticoid Receptor Antagonists No Benefit Post MI

0
MRA in addition to standard therapy does not improve outcome in setting of post-MI heart failure
Network meta-analysis

Network Meta-Analysis Recommends Prostaglandins for Glaucoma

0
Highest-ranking class for reducing intraocular pressure was prostaglandins for 1999, 2004, 2009
Two- and four-hour mixed-meal tolerance tests vary for C-peptide responses in type 1 diabetes

Mixed-Meal Tolerance Tests Vary for C-Peptide Response in T1DM

0
Variation in the percent of the total four-hour C-peptide AUC captured in first two hours
Donor Epstein-Barr virus serostatus influences incidence of graft-versus-host disease in patients with acute leukemia undergoing allogeneic hematopoietic stem-cell transplantation

Donor Epstein-Barr Serostatus Influences GVHD After Allo-HSCT

0
Higher risk of acute and chronic GVHD for patients receiving grafts from seropositive donors
More than one-third of advanced melanoma patients were still alive five years after starting therapy with nivolumab (Opdivo)

AACR: Nivolumab Appears to Up Survival in Advanced Melanoma

0
One-third of study participants lived five years or more after starting treatment